AZTA Fair Value Estimate
$30.7923.6% undervalued
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Azenta Inc
Exchange: NASDAQSector: HealthcareIndustry: Medical Instruments & Supplies
Brooks operates two global, market-leading businesses, Life Sciences and Semiconductor Solutions, each with its own distinct area of focus and expertise. The Life Sciences business, to be operated under the new Azenta brand, provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. On September 20, 2021, the Company announced the pending sale to Thomas H. Lee Partners of its Semiconductor Solutions Group business, which provides industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers as well as collaborative robotics and automation capabilities for multi-market applications. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia.
Did you know?
Generated $1.1 in free cash flow for every $1 of capital expenditure in FY25.
Current Price
$24.91
+1.38%GoodMoat Value
$30.79
23.6% undervaluedProfile
Valuation (TTM)
Market Cap$1.14B
P/E-19.71
EV—
P/B0.66
Shares Out45.78M
P/Sales1.92
Revenue$594.95M
EV/EBITDA—
Azenta Inc (AZTA) Valuation
AZTA Valuation Metrics
FCF$38.32M
FCF Growth Rate-8.90%
EPS Growth (CAGR)50.00%
WACC10.00%
Fair Value Models
Graham Number, PEG-based, and Earnings-based models
View Fair Value →AZTA Valuation & Fair Value Analysis
Azenta Inc (AZTA) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.
The GoodMoat Fair Value target for Azenta Inc is $30.79. The current stock price is $24.91, suggesting the stock is 23.6% undervalued.
The price-to-earnings (P/E) ratio is -19.71. Price-to-book ratio is 0.66. Price-to-sales ratio is 1.92. PEG ratio is -0.55.
GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Azenta Inc's intrinsic value.